Due to COVID-19 we are now offering TeleHealth Office Visits via video or phone call. Learn More >
We have prepared for the Coronavirus (COVID-19). We have updated policies to protect our patients and staff. Learn more.

News

  • Chemotherapy for Covid-19 Cancer Patients is Not Risky

    September 19, 2020
    Immunotherapy and chemotherapy have zero adverse effects on cancer patients diagnosed with Covid-19, according to research. Cancer patients infected with Covid-19 from Italy, UK, Germany, and Spain took part in the study. The research took place in 19 hospitals located in the four countries. According to the study, some cancer patients showed positive outcomes when given hydroxychloroquine drugs. However, some studies...read more
  • Can Antiandrogens Treat Human Glioblastomas?

    Glioblastomas are human brain tumors that invade the normal brain tissue. Therefore, glioblastoma progresses fast, as nothing slows down the growth of brain cancer. There’s a high volume of androgen receptors in GBM- intrinsic therapy-resistant. Can Antiandrogens be used to Kill Glioblastoma (GBM)? Anti-androgens slow down the pace at which cancer repairs damaged DNA instigated by treatment. The slow down...read more
  • Alternative Cancer Treatments – What You Need to Know

    The American Society of Clinical Oncology conducted a survey that showed that nearly 40 percent of Americans believe that alternative therapies alone can treat cancer. But the evidence points to the contrary – there's a higher mortality rate among individuals who use alternative treatments instead of conventional cancer treatments. The terms "complementary," "alternative," and "lifestyle" medicine often refer to various...read more
  • Blood Pressure Medication Can Lower Colon Cancer Risk

    August 26, 2020
    Colon cancer ranks third among the most common cancers and second among the top causes of cancer fatalities across the world. Recent research has found that there are two brands of blood pressure drugs that can also help treat colon cancer. These drugs include: ACE inhibitors (Angiotensin-converting enzyme inhibitors) and Angiotensin II Receptor Blockers (ARBs) About the Research and Its Findings The University of Hong...read more
  • Delaying Colonoscopy Screening May Affect Your Risk of Colorectal Cancer

    July 13, 2020
    The current colorectal cancer screening guidelines recommend that you should start screening at age 45 to 50 then once every 10 years if the results show negative. A new study suggests that a delay in having a colonoscopy may not affect cancer risk for people at low risk. Researchers analyzed men and women of 50 - 66 years who had been...read more
  • Utilizing Integrative Oncology to Enhance Patient Outcomes and their Quality of Life

    Integrative oncology involves using lifestyle-based integrative treatment (merging conventional and complementary medicine) approaches to improve the outcomes and quality of life of patients. According to a survey, integrative oncology is defined as a patient-centered, evidence-informed field of cancer care that utilizes natural products, lifestyle modifications from various traditions, mind and body practices alongside conventional cancer therapies such as immunotherapy, chemotherapy,...read more
  • Effects of Processed Meats on Cancer Risk

    June 15, 2020
    A lot of knowledge about cancer is available on the internet, but people still are looking for answers on which foods can help reduce their risk. Some research projects have confirmed some foods that may reduce your risk for cancer, while other foods have no evidence to back up their impact on cancer risk. For example, sugar is perceived to...read more
  • FDA Approves Chemo-Free Combination Drugs for Lung Cancer

    The FDA has approved a combination of drugs as first-line treatment for lung cancer. The combo includes ipilimumab (Yervoy, Bristol-Myers Squibb) and nivolumab (Opdivo, Bristol-Myers Squibb), which can treat patients with metastatic non-small cell lung cancer with tumors that express PD-LI (≥ 1%). The drugs are limited to lung cancer patients without the epidermal growth factor receptor or anaplastic...read more
  • Should You Get PSA Tests When you’re Over 75 Years?

    May 14, 2020
    It is recommended to start PSA screening at age 40 to 50 depending on your risks. Major professional bodies are against PSA screening for older adults with low life expectancy. They are concerned about patients being over-diagnosed and overtreated. Prostate cancer is often referred to as an old man’s disease, and many patients don’t die from prostate cancer, but from...read more
  • Gaining Weight can Help Minimize Breast Cancer Risks before Menopause

    New research has discovered that women who gain weight before menopause can reduce their risk of breast cancer. Weight may protect early adulthood women against breast cancer. A lot of women die from breast cancer in the United States. During a recent study; Researchers explored previous findings to discover if weight gain in women between 18 and 40 years affected their...read more

More Choice Cancer Care Centers